Real-world evidence shows clinically meaningful weight loss in people receiving Saxenda®
People treated with Saxenda® (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in…
Shield Therapeutics 2017 Loss Widens On Clinical Trials, Higher Costs
Shield Therapeutics PLC on Wednesday reported significantly widened loss for 2017, as it progresses on Feraccru product study and commercialisation.…